Gene expression changes of prostanoid synthases in endothelial cells and prostanoid receptors in vascular smooth muscle cells caused by aging and hypertension
- 1 February 2008
- journal article
- Published by American Physiological Society in Physiological Genomics
- Vol. 32 (3) , 409-418
- https://doi.org/10.1152/physiolgenomics.00136.2007
Abstract
The present study was designed to assess whether or not changes in genomic expression of cyclooxygenases (COX-1, COX-2), endothelial nitric oxide synthase (eNOS), and prostanoid synthases in the endothelium and of prostanoid receptors in vascular smooth muscle contribute to the occurrence of endothelium-dependent contractions during aging and hypertension. Gene expression was quantified by real-time PCR using isolated endothelial cells and smooth muscle cells (SMC) from the aorta of Wistar-Kyoto and spontaneously hypertensive rats. Genes for all known prostanoid synthases and receptors were present in endothelial cells and SMC, respectively. Aging caused overexpression of eNOS, COX-1, COX-2, thromboxane synthase, hematopoietic-type prostaglandin D synthase, membrane prostaglandin E synthase-2, and prostaglandin F synthase in endothelial cells and COX-1 and prostaglandin E2 (EP)4 receptors in SMC. Hypertension augmented the expression of COX-1, prostacyclin synthase, thromboxane synthase, and hematopoietic-type prostaglandin D synthase in endothelial cells and prostaglandin D2 (DP), EP3, and EP4 receptors in SMC. The increase in genomic expression of endothelial COX-1 explains why in aging and hypertension the endothelium has greater propensity to release cyclooxygenase-derived vasoconstrictive prostanoids. The expression of prostacyclin synthase was by far the most abundant, explaining why the majority of the COX-1-derived endoperoxides are transformed into prostacyclin, substantiating the role of prostacyclin as an endothelium-derived contracting factor. The expression of thromboxane synthase was increased in the cells of aging or hypertensive rats, explaining why the prostanoid can contribute to endothelium-dependent contractions. It is uncertain whether the gene modifications caused by aging and hypertension directly contribute to endothelium-dependent contractions or rather to vascular aging and the vascular complications of the hypertensive process.Keywords
This publication has 40 references indexed in Scilit:
- Mechanisms underlying ATP-induced endothelium-dependent contractions in the SHR aortaEuropean Journal of Pharmacology, 2007
- In SHR aorta, calcium ionophore A-23187 releases prostacyclin and thromboxane A2 as endothelium-derived contracting factorsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2006
- Prostanoid signal transduction and gene expression in the endothelium: Role in cardiovascular diseasesCardiovascular Research, 2006
- Acetylcholine‐induced endothelium‐dependent contractions in the SHR aorta: the Janus face of prostacyclinBritish Journal of Pharmacology, 2005
- Prostanoids and prostanoid receptors in signal transductionThe International Journal of Biochemistry & Cell Biology, 2004
- Microsomal Prostaglandin E Synthase-1 Is a Major Terminal Synthase That Is Selectively Up-Regulated During Cyclooxygenase-2-Dependent Prostaglandin E2 Production in the Rat Adjuvant-Induced Arthritis ModelThe Journal of Immunology, 2003
- Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assaysJournal of Molecular Endocrinology, 2000
- Cyclo‐oxygenase‐1 and −2 contribution to endothelial dysfunction in ageingBritish Journal of Pharmacology, 2000
- Endothelium-Dependent Contractions Are Associated With Both Augmented Expressionof Prostaglandin H Synthase-1 and Hypersensitivity to Prostaglandin H 2 in the SHR AortaCirculation Research, 1995
- Thromboxane A2 receptor antagonists inhibit endothelium-dependent contractions.Hypertension, 1990